$ Value
$14K
Shares
551
Price
$26
Filed
Jun 9
Insider
Name
Klinger Shannon Thyme
Title
Chief Legal Officer
CIK
0001866132
Roles
Transaction Details
Transaction Date
2025-06-06
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
27,483
Footnotes
Restricted stock units convert into common stock on a one-for-one basis. | Includes 595 shares acquired under the Moderna, Inc. 2018 Employee Stock Purchase Plan on May 30, 2025. | Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. | 25% of the shares subject to this restricted stock unit award vested on June 7, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter. This restricted stock unit award is fully vested as of June 6, 2025.
Filing Info
Klinger Shannon Thyme's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-05 | MRNA | M | — |
| 2025-12-05 | MRNA | F | $582K |
| 2025-12-05 | MRNA | M | $0 |
| 2025-12-01 | MRNA | M | — |
| 2025-12-01 | MRNA | F | $3K |
| 2025-12-01 | MRNA | M | $0 |
| 2025-11-28 | MRNA | M | — |
| 2025-11-28 | MRNA | F | $4K |
| 2025-11-28 | MRNA | M | $0 |
| 2025-11-26 | MRNA | M | — |
Other Insiders at MRNA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Mock James M
Chief Financial Officer
|
— | — | 2026-04-02 |